全文获取类型
收费全文 | 203207篇 |
免费 | 4486篇 |
国内免费 | 483篇 |
专业分类
耳鼻咽喉 | 2859篇 |
儿科学 | 7736篇 |
妇产科学 | 5929篇 |
基础医学 | 26467篇 |
口腔科学 | 6020篇 |
临床医学 | 15750篇 |
内科学 | 36881篇 |
皮肤病学 | 4939篇 |
神经病学 | 12420篇 |
特种医学 | 10948篇 |
外国民族医学 | 97篇 |
外科学 | 30483篇 |
综合类 | 1136篇 |
一般理论 | 7篇 |
预防医学 | 16792篇 |
眼科学 | 4444篇 |
药学 | 14153篇 |
2篇 | |
中国医学 | 179篇 |
肿瘤学 | 10934篇 |
出版年
2018年 | 3660篇 |
2017年 | 3980篇 |
2016年 | 3262篇 |
2015年 | 4998篇 |
2014年 | 4440篇 |
2013年 | 3669篇 |
2012年 | 10230篇 |
2011年 | 5164篇 |
2010年 | 2458篇 |
2009年 | 4120篇 |
2008年 | 2561篇 |
2007年 | 3344篇 |
2006年 | 3536篇 |
2005年 | 11630篇 |
2004年 | 13069篇 |
2003年 | 8665篇 |
2002年 | 3919篇 |
2001年 | 4517篇 |
2000年 | 1870篇 |
1999年 | 6023篇 |
1998年 | 624篇 |
1995年 | 476篇 |
1992年 | 6982篇 |
1991年 | 7199篇 |
1990年 | 7451篇 |
1989年 | 7043篇 |
1988年 | 6587篇 |
1987年 | 6318篇 |
1986年 | 6010篇 |
1985年 | 5319篇 |
1984年 | 3656篇 |
1983年 | 2971篇 |
1982年 | 1067篇 |
1981年 | 816篇 |
1980年 | 892篇 |
1979年 | 3900篇 |
1978年 | 2413篇 |
1977年 | 1829篇 |
1976年 | 1611篇 |
1975年 | 2521篇 |
1974年 | 3158篇 |
1973年 | 2779篇 |
1972年 | 2787篇 |
1971年 | 2764篇 |
1970年 | 2585篇 |
1969年 | 2495篇 |
1968年 | 2253篇 |
1967年 | 2184篇 |
1966年 | 1916篇 |
1965年 | 1145篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Buket Bakan Fatih Oltulu Yeliz Y?ld?r?m Altu? Yava?o?lu Sinan Akg?l Nefise ülkü Karabay Yava?o?lu 《Arhiv za higijenu rada i toksikologiju》2023,74(3):207
The aim of this safety study in mice was to determine in vivo toxicity and biodistribution potential of a single and multiple doses of L-glutamic acid-g-p(HEMA) polymeric nanoparticles as a drug delivery system. The single dose did not cause any lethal effect, and its acute oral LD50 was >2.000 mg/kg body weight (bw). Multiple doses (25, 50, or 100 mg/kg bw) given over 28 days resulted in no significant differences in body and relative organ weights compared to control. These results are supported by biochemical and histological findings. Moreover, nanoparticle exposure did not result in statistically significant differences in micronucleus counts in bone marrow cells compared to control. Nanoparticle distribution was time-dependent, and they reached the organs and even bone marrow by hour 6, as established by ex vivo imaging with the IVIS® spectrum imaging system. In conclusion, L-glutamic acid-g-p(HEMA) polymeric nanoparticles appear biocompatible and have a potential use as a drug delivery system.KEY WORDS: biocompatibility, blood biochemistry, genotoxicity, histology, in vivo toxicity, micronucleus test, polymers 相似文献
3.
4.
5.
6.
Brand Fabian Dendler Leonie Fiack Suzan Schulze Annett Böl Gaby-Fleur 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(5):599-607
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Regulierungswissenschaftliche Organisationen wie das Bundesinstitut für Risikobewertung (BfR) sehen sich in ihrer... 相似文献
7.
8.
Alessandro De Cassai Tommaso Tonetti Helmut Galligioni Carlo Ori 《Brazilian Journal of Anesthesiology》2019,69(1):95-98
Background and objective
Erector spinae plane block is a valid technique to provide simultaneously analgesia for combined thoracic and abdominal surgery.Case report
A patient underwent open esophagectomy followed by reconstructive esophagogastroplasty but refused thoracic epidural analgesia; a multi‐modal analgesia with a multiple erector spinae plane block was then planned. Three erector spinae plane catheters (T5 and T10 on the right side and T9 on the left side) for continuous analgesia were placed before surgery. During the first 48 h pain was never reported in the thoracic area but the patient reported multiple times to feel a pain well localized in epigastrium, but never localized in any other abdominal quadrant.Discussion
Erector spinae plane block is a valid technique to provide analgesia simultaneously for combined thoracic and abdominal surgery and could be a valid alternative strategy if the use of epidural analgesia is contraindicated. 相似文献9.
10.
Raphael L. C. Araujo MD PhD Jean Michel Milani MD Daniela Pezzutti Armentano MD Raphael Brandão Moreira MD Gustavo S. F. Pinto MD Luís Antônio de Castro MD Fabiano R. Lucchesi MD PhD 《Journal of surgical oncology》2020,121(5):848-856
The mainstays of treatment for colorectal liver metastases (CRLMs) are surgery and chemotherapy. Chemotherapeutic benefits of tumor shrinkage and systemic control of micrometastases are in part counterbalanced by chemotoxicity that can modify the liver parenchyma, jeopardizing the detection of CRLM. This review addresses the clinical decision-making process in the context of radiographic and pathologic responses, the preoperative imaging workup, and the approaches to the liver for CRLM, which disappear after systemic chemotherapy. 相似文献